Global Sexually Transmitted Diseases Testing Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Sexually Transmitted Diseases Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Chlamydia Testing
  • 1.2.3 Gonorrhea Testing
  • 1.2.4 Syphilis Testing
  • 1.2.5 HIV Testing
  • 1.2.6 HSV Testing
  • 1.2.7 HPV Testing
  • 1.2.8 Chancroid Testing
  • 1.2.9 Other
• 1.3 Market by Application
  • 1.3.1 Global Sexually Transmitted Diseases Testing Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Clinics
  • 1.3.3 Hospitals
  • 1.3.4 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Sexually Transmitted Diseases Testing Market Perspective (2016-2027)
• 2.2 Sexually Transmitted Diseases Testing Growth Trends by Regions
  • 2.2.1 Sexually Transmitted Diseases Testing Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Sexually Transmitted Diseases Testing Historic Market Share by Regions (2016-2021)
  • 2.2.3 Sexually Transmitted Diseases Testing Forecasted Market Size by Regions (2022-2027)
• 2.3 Sexually Transmitted Diseases Testing Industry Dynamic
  • 2.3.1 Sexually Transmitted Diseases Testing Market Trends
  • 2.3.2 Sexually Transmitted Diseases Testing Market Drivers
  • 2.3.3 Sexually Transmitted Diseases Testing Market Challenges
  • 2.3.4 Sexually Transmitted Diseases Testing Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Sexually Transmitted Diseases Testing Players by Revenue
  • 3.1.1 Global Top Sexually Transmitted Diseases Testing Players by Revenue (2016-2021)
  • 3.1.2 Global Sexually Transmitted Diseases Testing Revenue Market Share by Players (2016-2021)
• 3.2 Global Sexually Transmitted Diseases Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Sexually Transmitted Diseases Testing Revenue
• 3.4 Global Sexually Transmitted Diseases Testing Market Concentration Ratio
  • 3.4.1 Global Sexually Transmitted Diseases Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases Testing Revenue in 2020
• 3.5 Sexually Transmitted Diseases Testing Key Players Head office and Area Served
• 3.6 Key Players Sexually Transmitted Diseases Testing Product Solution and Service
• 3.7 Date of Enter into Sexually Transmitted Diseases Testing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Sexually Transmitted Diseases Testing Breakdown Data by Type

• 4.1 Global Sexually Transmitted Diseases Testing Historic Market Size by Type (2016-2021)
• 4.2 Global Sexually Transmitted Diseases Testing Forecasted Market Size by Type (2022-2027)

5 Sexually Transmitted Diseases Testing Breakdown Data by Application

• 5.1 Global Sexually Transmitted Diseases Testing Historic Market Size by Application (2016-2021)
• 5.2 Global Sexually Transmitted Diseases Testing Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Sexually Transmitted Diseases Testing Market Size (2016-2027)
• 6.2 North America Sexually Transmitted Diseases Testing Market Size by Type
  • 6.2.1 North America Sexually Transmitted Diseases Testing Market Size by Type (2016-2021)
  • 6.2.2 North America Sexually Transmitted Diseases Testing Market Size by Type (2022-2027)
  • 6.2.3 North America Sexually Transmitted Diseases Testing Market Size by Type (2016-2027)
• 6.3 North America Sexually Transmitted Diseases Testing Market Size by Application
  • 6.3.1 North America Sexually Transmitted Diseases Testing Market Size by Application (2016-2021)
  • 6.3.2 North America Sexually Transmitted Diseases Testing Market Size by Application (2022-2027)
  • 6.3.3 North America Sexually Transmitted Diseases Testing Market Size by Application (2016-2027)
• 6.4 North America Sexually Transmitted Diseases Testing Market Size by Country
  • 6.4.1 North America Sexually Transmitted Diseases Testing Market Size by Country (2016-2021)
  • 6.4.2 North America Sexually Transmitted Diseases Testing Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe Sexually Transmitted Diseases Testing Market Size (2016-2027)
• 7.2 Europe Sexually Transmitted Diseases Testing Market Size by Type
  • 7.2.1 Europe Sexually Transmitted Diseases Testing Market Size by Type (2016-2021)
  • 7.2.2 Europe Sexually Transmitted Diseases Testing Market Size by Type (2022-2027)
  • 7.2.3 Europe Sexually Transmitted Diseases Testing Market Size by Type (2016-2027)
• 7.3 Europe Sexually Transmitted Diseases Testing Market Size by Application
  • 7.3.1 Europe Sexually Transmitted Diseases Testing Market Size by Application (2016-2021)
  • 7.3.2 Europe Sexually Transmitted Diseases Testing Market Size by Application (2022-2027)
  • 7.3.3 Europe Sexually Transmitted Diseases Testing Market Size by Application (2016-2027)
• 7.4 Europe Sexually Transmitted Diseases Testing Market Size by Country
  • 7.4.1 Europe Sexually Transmitted Diseases Testing Market Size by Country (2016-2021)
  • 7.4.2 Europe Sexually Transmitted Diseases Testing Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Sexually Transmitted Diseases Testing Market Size (2016-2027)
• 8.2 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Type
  • 8.2.1 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Application
  • 8.3.1 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Region
  • 8.4.1 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Sexually Transmitted Diseases Testing Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Sexually Transmitted Diseases Testing Market Size (2016-2027)
• 9.2 Latin America Sexually Transmitted Diseases Testing Market Size by Type
  • 9.2.1 Latin America Sexually Transmitted Diseases Testing Market Size by Type (2016-2021)
  • 9.2.2 Latin America Sexually Transmitted Diseases Testing Market Size by Type (2022-2027)
  • 9.2.3 Latin America Sexually Transmitted Diseases Testing Market Size by Type (2016-2027)
• 9.3 Latin America Sexually Transmitted Diseases Testing Market Size by Application
  • 9.3.1 Latin America Sexually Transmitted Diseases Testing Market Size by Application (2016-2021)
  • 9.3.2 Latin America Sexually Transmitted Diseases Testing Market Size by Application (2022-2027)
  • 9.3.3 Latin America Sexually Transmitted Diseases Testing Market Size by Application (2016-2027)
• 9.4 Latin America Sexually Transmitted Diseases Testing Market Size by Country
  • 9.4.1 Latin America Sexually Transmitted Diseases Testing Market Size by Country (2016-2021)
  • 9.4.2 Latin America Sexually Transmitted Diseases Testing Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Sexually Transmitted Diseases Testing Market Size (2016-2027)
• 10.2 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Type
  • 10.2.1 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Application
  • 10.3.1 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Country
  • 10.4.1 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Sexually Transmitted Diseases Testing Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 BioMerieux
  • 11.1.1 BioMerieux Company Details
  • 11.1.2 BioMerieux Business Overview
  • 11.1.3 BioMerieux Sexually Transmitted Diseases Testing Introduction
  • 11.1.4 BioMerieux Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
  • 11.1.5 BioMerieux Recent Development
• 11.2 F. Hoffmann La Roche
  • 11.2.1 F. Hoffmann La Roche Company Details
  • 11.2.2 F. Hoffmann La Roche Business Overview
  • 11.2.3 F. Hoffmann La Roche Sexually Transmitted Diseases Testing Introduction
  • 11.2.4 F. Hoffmann La Roche Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
  • 11.2.5 F. Hoffmann La Roche Recent Development
• 11.3 BD
  • 11.3.1 BD Company Details
  • 11.3.2 BD Business Overview
  • 11.3.3 BD Sexually Transmitted Diseases Testing Introduction
  • 11.3.4 BD Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
  • 11.3.5 BD Recent Development
• 11.4 Abbott
  • 11.4.1 Abbott Company Details
  • 11.4.2 Abbott Business Overview
  • 11.4.3 Abbott Sexually Transmitted Diseases Testing Introduction
  • 11.4.4 Abbott Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
  • 11.4.5 Abbott Recent Development
• 11.5 Bio-Rad Laboratories
  • 11.5.1 Bio-Rad Laboratories Company Details
  • 11.5.2 Bio-Rad Laboratories Business Overview
  • 11.5.3 Bio-Rad Laboratories Sexually Transmitted Diseases Testing Introduction
  • 11.5.4 Bio-Rad Laboratories Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
  • 11.5.5 Bio-Rad Laboratories Recent Development
• 11.6 Abbott
  • 11.6.1 Abbott Company Details
  • 11.6.2 Abbott Business Overview
  • 11.6.3 Abbott Sexually Transmitted Diseases Testing Introduction
  • 11.6.4 Abbott Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
  • 11.6.5 Abbott Recent Development
• 11.7 Qiagen
  • 11.7.1 Qiagen Company Details
  • 11.7.2 Qiagen Business Overview
  • 11.7.3 Qiagen Sexually Transmitted Diseases Testing Introduction
  • 11.7.4 Qiagen Revenue in Sexually Transmitted Diseases Testing Business (2016-2021)
  • 11.7.5 Qiagen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer